ORALLY DISINTEGRATING TABLET CONTAINING NALFURAFINE

Title:

ORALLY DISINTEGRATING TABLET CONTAINING NALFURAFINE

Document Type and Number:

WIPO Patent Application WO/2020/017808

Kind Code:

A1

Abstract:

The present invention provides an orally disintegrating tablet containing nalfurafine, dimethylaminoethyl methacrylate·methyl methacrylate copolymer, tocopherol polyethyleneglycol succinate as an antioxidant, and sodium lauryl sulfate as a solubilizer.

Inventors:

JEON BORAMI (KR)
PARK JINYOUNG (KR)
CHUNG YOUNGSIK (KR)
SHIN HYUN IK (KR)

Application Number:

PCT/KR2019/008397

Publication Date:

January 23, 2020

Filing Date:

July 09, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

YONSUNG FINE CHEMICAL CO LTD (KR)

International Classes:

A61K9/00; A61K9/20; A61K31/485; A61P17/04

Foreign References:

US20160081939A1	2016-03-24
KR20090034372A	2009-04-07
KR20150029753A	2015-03-18
KR20130141474A	2013-12-26
JP2017039694A	2017-02-23

Attorney, Agent or Firm:

YU, Su Mi (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD AND APPARATUS FOR TRANSMITTING PDCP STATUS REPORT IN WIRELESS COMMUNICATION SYSTEM

Next Patent: ELECTRODE ASSEMBLY MANUFACTURING APPARATUS EQUIPPED WITH AIR PURIFYING FUNCTION